Table 5.
Toxicity and safety
| EG(N = 119),n(%) | CG(N = 98), n(%) | p -value | |
|---|---|---|---|
| Radiation dermatitis | |||
| Grade 0 | 91 (76.5%) | 81 (82.7%) | 0.264 |
| GradeI-II | 23 (19.3%) | 15 (15.3%) | 0.438 |
| Grade III-IV | 5 (4.2%) | 2 (2.0%) | 0.461 |
| Radiation cystitis | |||
| Grade 0 | 97 (81.5%) | 79 (80.6%) | 0.866 |
| GradeI-II | 22 (18.5%) | 19 (19.4%) | 0.866 |
| Grade III-IV | 0 (0%) | 0 (0%) | |
| Radiation enteritis | |||
| Grade 0 | 43 (36.1%) | 45 (45.9%) | 0.144 |
| GradeI-II | 57 (47.9%) | 45 (45.9%) | 0.771 |
| Grade III-IV | 19 (16%) | 8 (8.2%) | 0.083 |
| Bone Marrow suppression | |||
| Grade 0 | 11 (9.25%) | 8 (8.2%) | 0.779 |
| GradeI-II | 83 (69.75%) | 73 (74.5%) | 0.439 |
| Grade III-IV | 25 (21.0%) | 17 (17.3%) | 0.497 |
EG The experimental group, CG The control group